ENTRADA THERAPEUTICS

Serial Number 88904724
Registration 7422339
700

Registration Progress

Application Filed
May 7, 2020
Under Examination
May 11, 2021
Approved for Publication
Mar 16, 2021
Published for Opposition
Mar 16, 2021
Registered
Jun 18, 2024

Trademark Image

ENTRADA THERAPEUTICS

Basic Information

Serial Number
88904724
Registration Number
7422339
Filing Date
May 7, 2020
Registration Date
June 18, 2024
Published for Opposition
March 16, 2021
Drawing Code
3

Status Summary

Current Status
Active
Status Code
700
Status Date
Jun 18, 2024
Registration
Registered
Classes
005 042

Rights Holder

Entrada Therapeutics, Inc.

03
Address
One Design Center Pl, Suite 17-500
Boston, MA 02210

Ownership History

Entrada Therapeutics, Inc.

Original Applicant
03
Boston, MA

Entrada Therapeutics, Inc.

Owner at Publication
03
Boston, MA

Entrada Therapeutics, Inc.

Original Registrant
03
Boston, MA

Legal Representation

Attorney
Stephanie H. Bald

USPTO Deadlines

Next Deadline
1609 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20240618)
Due Date
June 18, 2030
Grace Period Ends
December 18, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

50 events
Date Code Type Description Documents
Jun 18, 2024 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Jun 18, 2024 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
May 13, 2024 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
May 13, 2024 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Apr 16, 2024 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Apr 11, 2024 IUAF S USE AMENDMENT FILED Loading...
Apr 11, 2024 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Nov 14, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Nov 13, 2023 EX5G S SOU EXTENSION 5 GRANTED Loading...
Nov 7, 2023 EXT5 S SOU EXTENSION 5 FILED Loading...
Nov 13, 2023 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Nov 7, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jul 24, 2023 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Jul 24, 2023 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Jul 24, 2023 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Jul 24, 2023 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Jul 24, 2023 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Apr 20, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Apr 18, 2023 EX4G S SOU EXTENSION 4 GRANTED Loading...
Apr 18, 2023 EXT4 S SOU EXTENSION 4 FILED Loading...
Apr 18, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 26, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 24, 2022 EX3G S SOU EXTENSION 3 GRANTED Loading...
Oct 24, 2022 EXT3 S SOU EXTENSION 3 FILED Loading...
Oct 24, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Apr 16, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Apr 14, 2022 EX2G S SOU EXTENSION 2 GRANTED Loading...
Apr 14, 2022 EXT2 S SOU EXTENSION 2 FILED Loading...
Apr 14, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 29, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 27, 2021 EX1G S SOU EXTENSION 1 GRANTED Loading...
Oct 27, 2021 EXT1 S SOU EXTENSION 1 FILED Loading...
Oct 27, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
May 21, 2021 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
May 21, 2021 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
May 21, 2021 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
May 11, 2021 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Mar 16, 2021 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Mar 16, 2021 PUBO A PUBLISHED FOR OPPOSITION Loading...
Feb 24, 2021 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Feb 7, 2021 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Feb 5, 2021 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Feb 5, 2021 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Feb 5, 2021 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Aug 10, 2020 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Aug 10, 2020 GNRT F NON-FINAL ACTION E-MAILED Loading...
Aug 10, 2020 CNRT R NON-FINAL ACTION WRITTEN Loading...
Aug 4, 2020 DOCK D ASSIGNED TO EXAMINER Loading...
May 22, 2020 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
May 21, 2020 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...

Detailed Classifications

Class 005
House mark for a full line of pharmaceuticals, but not including pharmaceuticals intended to treat multiple sclerosis or related diseases or conditions related to multiple sclerosis, all of the foregoing specifically excluding pharmaceutical preparations for the treatment of cancer
First Use Anywhere: Jun 14, 2022
First Use in Commerce: Jun 14, 2022
Class 042
Pharmaceutical research and development services
First Use Anywhere: 20230200
First Use in Commerce: 20230200

Additional Information

Design Mark
The mark consists of a design of five curved lines. The center of each line meets at the right side of the design, and the lines fan out to the left both above and below the center, forming an overall shape that resembles a curved arrow pointing to the right. The lines increase in width from left to right. To the right of the design is the stylized word "ENTRADA", with the stylized word "THERAPEUTICS" underneath.
Color Claim
Color is not claimed as a feature of the mark.
Translation
The English translation of "ENTRADA" in the mark is "ENTRY".

Classification

International Classes
005 042

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"THERAPEUTICS"